Avon Technologies surged almost 12% after saying its financial 2026 margins and returns would exceed guidance, and it set out new medium-term targets ahead of its results on 10 November.

Avon Technologies (LSE:AVON), the Wiltshire-based maker of respiratory protection and head protection equipment for military and first responder customers, delivered one of the largest share price moves in the FTSE 250 this month. On 7 October the company published a trading update for its financial year to the end of September, saying performance had beaten expectations. The shares rose 11.9% to around 2,135p by mid-morning.

The update marked a further step in a turnaround that has seen the company recover from a period of difficulties in its body armour operations, which it exited, to focus on its core protection products.

Margins ahead of guidance

Avon (LSE:AVON) said revenue for financial 2026 was expected to grow by around 12.5%. More significantly for investors, the adjusted operating margin was expected to exceed the company's guidance range of 14% to 16%, and return on invested capital was also ahead of guidance.

The company said its order book had risen sharply since the half-year point, although it did not provide a specific figure. Year-end net debt, excluding leases, was expected to be about $34 million, with cash conversion above 85% and leverage below 0.5 times earnings. Avon reports in US dollars, reflecting the importance of its American defence and first responder customers.

Earlier in the year, at its first-quarter update, Avon had held guidance despite slower trading in the US, citing high demand. The latest statement suggests momentum improved significantly through the second half.

New medium-term ambitions

Alongside the trading update, Avon set out new medium-term targets. It is aiming for annual revenue growth of more than 5%, an adjusted operating margin of 16% to 18% and earnings per share growth above 10%. The company also targets free cash flow of more than $175 million over the next three years, revenue of more than $600 million within five years, and return on invested capital above 18%.

The upgraded margin range implies further operational improvement from current levels, building on efficiency work, pricing and a richer product mix. Avon's portfolio includes respirators and powered air systems used by armed forces and emergency services, as well as helmets and other head protection products.

Defence tailwinds

The broader backdrop has been supportive. Governments in Europe and North America have increased defence spending in response to heightened geopolitical tension, and demand for personal protective equipment for soldiers and first responders has benefited. Avon's established relationships with the US Department of Defense and NATO forces position it to compete for multi-year contracts, although the timing of large orders can make revenue lumpy.

The share price reaction also reflects how sentiment towards the company has changed. A few years ago, Avon was grappling with problems in its armour business, contract delays and a weaker margin profile. Management has since simplified the group, concentrated on products where it holds leading positions and focused on operational efficiency. The latest update suggests that work is now feeding through to profitability and cash generation more quickly than the market had anticipated.

Avon will publish full-year results on 10 November, when it is expected to give guidance for financial 2027. Investors will be watching for more detail on the size of the order book, the outlook for US demand and progress towards the new margin targets. Capital allocation, including the potential for acquisitions given the low level of debt, may also be in focus.